Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human papillomavirus type 18 (HPV-18) is a high-risk HPV subtype strongly associated with cervical and other cancers. Its oncogenic potential stems from viral proteins E6 and E7, which disrupt cell cycle regulation. Prophylactic vaccines targeting HPV-18 can prevent infection and reduce cancer risk. HPV-18 exhibits genetic diversity with multiple lineages and sequence variants.
Vaccines stimulate an immune response to prevent infection. E6 and E7 oncoproteins promote degradation of tumor suppressor p53 and inactivate retinoblastoma protein pRb, leading to uncontrolled cell proliferation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human papillomavirus type 18 (HPV-18).